Mode
Text Size
Log in / Sign up

Global bibliometric analysis reveals neuroendoscopy research evolution from conservative treatment to augmented reality over two decades.

Global bibliometric analysis reveals neuroendoscopy research evolution from conservative treatment t…
Photo by Abdulai Sayni / Unsplash
Key Takeaway
Note that bibliometric data reflect research trends rather than clinical efficacy or safety for neuroendoscopy in intracranial hemorrhage.

This bibliometric analysis examined the global research architecture and evolution of neuroendoscopic interventions for intracranial hemorrhage. The review included 403 articles authored by researchers from 555 institutions spanning 43 countries over the past two decades. No comparator group or specific clinical outcomes were evaluated as this study mapped the literature rather than testing a treatment.

The publication trajectory showed fluctuating growth, with China contributing the highest number of publications and citation impact, followed by the United States. Research keywords evolved from terms like 'intracerebral hemorrhage' and 'initial conservative treatment' to 'augmented reality,' reflecting changing technological interests. Thematic progression moved from early emphasis on operative feasibility and safety toward more rigorous evidence appraisal and refinement of context-specific clinical indications.

Safety data, adverse events, and tolerability were not reported in this review. Key limitations include the absence of clinical outcome data, as the study design was observational and descriptive rather than interventional. The findings describe the state of research rather than clinical performance. Practice relevance suggests neuroendoscopy is positioned as a cornerstone of modern intracranial hemorrhage management, reshaping strategies toward precision and minimal invasiveness based on the evolution of the literature.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
ObjectiveNeuroendoscopy has emerged as a crucial minimally invasive strategy for the treatment of intracranial hemorrhage (ICH). This bibliometric analysis aims to systematically delineate the global research architecture and evolution of neuroendoscopic ICH research over the past two decades. MethodsRelevant publications were retrieved from the Web of Science Core Collection using a reproducible search strategy. Bibliometric tools were applied to analyze contributions from countries, institutions, authors, publications, keywords and journals, enabling the construction of a comprehensive knowledge map and evolutionary framework of this field. ResultsA total of 403 articles were identified, involving 2128 authors from 555 institutions across 43 countries. The publication trajectory exhibited fluctuating growth, reflecting the dynamic interplay between clinical demand and technological maturation. China contributed the highest publications and citation impact, followed by the US, jointly anchoring the global influence of the field. The research keywords have evolved from "intracerebral hemorrhage" and "initial conservative treatment" to "augmented reality." Thematic evolution analysis revealed a clear progression from early emphasis on operative feasibility, safety, and perioperative outcomes toward more rigorous evidence appraisal and the refinement of context-specific clinical indications, accompanied by continuous technological innovation. ConclusionThese findings collectively position neuroendoscopy as a cornerstone of modern ICH management, reshaping clinical strategies toward precision, minimal invasiveness, and multimodal intervention. Future progress will depend on strengthened international collaboration to generate high-quality evidence that supports patient stratification. The integration of emerging technologies, including advanced endoscopic robotics, is expected to further accelerate the translational and clinical landscape of neuroendoscopic ICH therapy.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.